Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly TPF Induction for Head and Neck Cancer
NCT04397341Phase 2Completed
- Sponsor
- China Medical University Hospital
- Start
- Mar 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil in squamous cell carcinoma of the head and neck (HNSCC), sponsored by China Medical University Hospital. Started Mar 2014; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT04397341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04397341.